Gracell Biotechnologies Stock Equity Positions Weight
Gracell Biotechnologies fundamentals help investors to digest information that contributes to Gracell Biotechnologies' financial success or failures. It also enables traders to predict the movement of Gracell Stock. The fundamental analysis module provides a way to measure Gracell Biotechnologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gracell Biotechnologies stock.
Gracell |
Gracell Biotechnologies Company Equity Positions Weight Analysis
Gracell Biotechnologies' Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
More About Equity Positions Weight | All Equity Analysis
Stock Percentage | = | % of Equities | in the fund |
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
CompetitionAccording to the company disclosure, Gracell Biotechnologies has an Equity Positions Weight of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Gracell Fundamentals
Return On Equity | -0.32 | |||
Return On Asset | -0.19 | |||
Current Valuation | 3.32 B | |||
Shares Outstanding | 96.57 M | |||
Shares Owned By Insiders | 16.39 % | |||
Shares Owned By Institutions | 63.11 % | |||
Number Of Shares Shorted | 1.19 M | |||
Price To Book | 4.39 X | |||
Price To Sales | 732.21 X | |||
Gross Profit | 366 K | |||
EBITDA | (509.64 M) | |||
Net Income | (496.98 M) | |||
Cash And Equivalents | 1.71 B | |||
Cash Per Share | 25.28 X | |||
Total Debt | 182.98 M | |||
Debt To Equity | 0.11 % | |||
Current Ratio | 8.01 X | |||
Book Value Per Share | 16.90 X | |||
Cash Flow From Operations | (482.65 M) | |||
Short Ratio | 0.87 X | |||
Earnings Per Share | (0.97) X | |||
Target Price | 10.58 | |||
Number Of Employees | 314 | |||
Beta | -0.34 | |||
Market Capitalization | 989.87 M | |||
Total Asset | 1.66 B | |||
Retained Earnings | (1.63 B) | |||
Working Capital | 1.28 B | |||
Z Score | 1.78 | |||
Net Asset | 1.66 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Gracell Stock
If you are still planning to invest in Gracell Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gracell Biotechnologies' history and understand the potential risks before investing.
Global Correlations Find global opportunities by holding instruments from different markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |